Novel class of drug regresses active brain metastases in breast cancer patients

[News]

An Austrian study led by MedUni Vienna showed that active brain metastases in breast cancer patients are partially or even completely regressed by a novel class of drug. This is a chemical conjugate of an antibody and a chemotherapy drug that, according to current findings, opens up a completely new avenue in oncological research and targeted therapy.

More... (https://www.news-medical.net/news/20220810/Novel-class-of-drug-regresses-active-brain-metastases-in-breast-cancer-patients.aspx)